Posts Tagged ‘biomarkers’
Differences So Clear
New Research Brings Clear Differences to Light in ME/CFS by Suzanne D. Vernon, PhD | BHC Research Liaison There is a great song in the musical RENT titled “Seasons of Love” in which they sing about the number of minutes in a year. As I am reviewing and writing this summary of the recent paper, “Epigenetic…
Read MoreNovel Gene Variants in ME/CFS and Fibromyalgia
Presented by Alan R. Light, PhD. In February 2017, Dr. Light began a new NIH-funded research grant, Novel Gene Variants in ME/CFS and Fibromyalgia. This is a continuation of earlier work which discovered a number of novel variants in both chromosomal and mitochondrial genes that could contribute to the symptoms found in patients. This talk…
Read MoreDr. Bateman Determined to Power-Up in 2017
Dr. Bateman, BHC founder and medical director, reflects on the progress in 2016 and plans to power-up her dedication to patients. __________ The “wear wild socks” year was amazing, marked by the quick-paced steps of the turtle-carrying-hares toward illness recognition and biomarker discovery. (Read how it all began HERE.) The recipe for this success has been…
Read MoreA Report of Research Progress in 2016
Because of the investment of many supporters – donors large and small – the Bateman Horne Center (BHC) has been able to partner with cutting-edge researchers across the globe. BHC works directly with researchers to enroll well-categorized patients into their research, providing samples with material transfer agreements in place so that we continue to learn from…
Read MoreA Report of Clinical Progress in 2016
Improved objective diagnosis and the ability to assess treatment outcomes, has made many aspects of MECFS and FM appear before my eyes. I am committed to infusing the medical community with this information to dramatically improve patient diagnosis and treatment. Careful observation of 10 minute NASA Lean test results as part of the CDC multisite…
Read MoreGlobal Report of Progress with Lucinda Bateman, M.D.
An ME/CS Progress Report Lucinda Bateman, MD, BHC Founder and Medical Director, is actively engaged in ME/CFS and FM thought leadership across the globe. In October she was on the road to take part in and advance the discussions that lead to progress. In a few short weeks she participated in: October 8th – SMCI Scientific…
Read MoreWhat’s the Buzz – October
Buzz – October: Each month we scour the Internet to bring you a summary of news articles, blogs and research publications we think you’ll find interesting for our What’s the Buzz post. This month, Suzanne D. Vernon, PhD, BHC Research Liaison, highlights and summarize two recent research publications for you: The Importance of Measuring Symptoms ME/CFS is…
Read MoreSimple Way to Assess Orthostatic Intolerance
NASA 10 Minute Lean Test* Orthostatic intolerance (OI) is an umbrella term used to describe abnormal autonomic nervous system response to orthostatic challenge. Orthostatic hypotension (OH), neurally mediated hypotension (NMH) [or neurogenic hypotension] and postural orthostatic tachycardia syndrome (PoTS) are terms used to describe variants of this response. The new evidence-based IOM clinical criteria for…
Read MoreWhat’s the Buzz – September
Buzz – September: Each month we scour the Internet and bring you a list of news articles, blogs and research publications we think you’ll find interesting for our What’s the Buzz post. Occasionally, we’ll highlight and summarize a few of them for you, like this one: Confirming a Potential ME/CFS Biomarker by Suzanne D. Vernon, PhD |…
Read MoreBHC Raises $1.08 Million, Moving to New Facility!
We’re Moving! In our spring campaign we laid out an audacious goal to raise $300,000 that would allow us to move into a larger facility in order to serve more patients, expand education efforts, and increase research participation. We are thrilled to announce that we have exceeded our goal by more than 260%, raising more than…
Read More